ConductScience.org, home

Paper34859337

Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens.

Shah GL and 13 others. Clin Pharmacokinet, 2022. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens. Papers, record 34859337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34859337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2026-11-02
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shah GLGunjan L
2Boelens JJJaap Jan
3Carlow DDean
4Lin AAndrew
5Schofield RRyan
6Cruz Sitner NNancy
7Alperovich AAnna
8Ruiz JJosel
9Proli AAnthony
10Dahi PParastoo
11Tamari RRoni
12Giralt SASergio A
13Scordo MMichael
14Admiraal RRickhttps://orcid.org/0000-0003-1512-2791

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem Cell TransplantationMajor topic
MelphalanMajor topic
Adult
Cohort Studies
Humans
Obesity
Transplant Recipients

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIHNIH RePORTER
UL1 TR001873NCATS NIH HHSUnited StatesUL1TR001873PubMedNIH RePORTER
UL1 TR002384NCATS NIH HHSUnited StatesUL1TR002384PubMedNIH RePORTER
P01 CA23766NIH HHSUnited StatesP01CA023766PubMed and NIHNIH RePORTER

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115255794What is the best size descriptor to use for pharmacokinetic studies in the obese?Br J Clin Pharmacol2004https://conductscience.org/library/papers/15255794PubMed
224662419Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma.Bone Marrow Transplant2014https://conductscience.org/library/papers/24662419PubMed
311768292Ways to fit a PK model with some data below the quantification limit.J Pharmacokinet Pharmacodyn2001https://conductscience.org/library/papers/11768292PubMed
431376591Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci2019https://conductscience.org/library/papers/31376591PubMed
531324638Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes.Blood Adv2019https://conductscience.org/library/papers/31324638PubMed
619414839A new equation to estimate glomerular filtration rate.Ann Intern Med2009https://conductscience.org/library/papers/19414839PubMed
717324241Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients.Br J Clin Pharmacol2007https://conductscience.org/library/papers/17324241PubMed
818066703Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.Curr Treat Options Oncol2007https://conductscience.org/library/papers/18066703PubMed
916176118Quantification of lean bodyweight.Clin Pharmacokinet2005https://conductscience.org/library/papers/16176118PubMed
10445964Kinetics of intravenous melphalan.Clin Pharmacol Ther1979https://conductscience.org/library/papers/445964PubMed
1124914142Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.Blood2014https://conductscience.org/library/papers/24914142PubMed
1228160288Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial.Clin Pharmacol Ther2017https://conductscience.org/library/papers/28160288PubMed
138649495A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.N Engl J Med1996https://conductscience.org/library/papers/8649495PubMed
14498715Oral melphalan kinetics.Clin Pharmacol Ther1979https://conductscience.org/library/papers/498715PubMed
1530471339Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30471339PubMed
1617914442Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects.Clin Pharmacol Ther2008https://conductscience.org/library/papers/17914442PubMed
1732609726Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma.PLoS One2020https://conductscience.org/library/papers/32609726PubMed
1820956629Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.J Clin Oncol2010https://conductscience.org/library/papers/20956629PubMed
1930390059Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma.Bone Marrow Transplant2019https://conductscience.org/library/papers/30390059PubMed
2028918602Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.Clin Pharmacokinet2018https://conductscience.org/library/papers/28918602PubMed

See all 37 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42756177Toward adaptive therapeutic timing: integration of mechanistic pharmacology and artificial intelligence in precision dosing.Front Pharmacol2026https://conductscience.org/library/papers/42756177PubMed
42654041Accuracy of Real-Time PK-Guided Melphalan Dosing in Achieving Target Exposure in Myeloma Patients Undergoing Autologous Transplant.Pharmaceutics2026https://conductscience.org/library/papers/42654041PubMed
42418372Alternative conditioning regimens for hemoglobinopathy gene therapy: balancing efficacy, toxicity, and the next frontier.Blood Adv2026https://conductscience.org/library/papers/42418372PubMed
42174044Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism.Bone Marrow Transplant2026https://conductscience.org/library/papers/42174044PubMed
42053946Population Pharmacokinetics of Melphalan in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation with Various Conditioning Regimens.Eur J Drug Metab Pharmacokinet2026https://conductscience.org/library/papers/42053946PubMed
40616382Precision transplant and cell therapies for non-malignant disorders-The path forward.Br J Haematol2025https://conductscience.org/library/papers/40616382PubMed
40214172The Impact of Melphalan Conditioning and CD34 + Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis.Am J Hematol2025https://conductscience.org/library/papers/40214172PubMed
40185404High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.Transplant Cell Ther2025https://conductscience.org/library/papers/40185404PubMed
39602148Model-based dosing for better survival after transplantation.Blood Adv2024https://conductscience.org/library/papers/39602148PubMed
39343716Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma.Clin Lymphoma Myeloma Leuk2025https://conductscience.org/library/papers/39343716PubMed
38097487Optimizing high dose melphalan.Blood Rev2024https://conductscience.org/library/papers/38097487PubMed
37379285Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.Blood Adv2023https://conductscience.org/library/papers/37379285PubMed
35545213Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation.Transplant Cell Ther2022https://conductscience.org/library/papers/35545213PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34859337

GET https://conductscience.org/api/papers/v1/34859337/references?page=2